scholarly journals Myeloid leukemia cell differentiation protein (MCL1); IL-24 (MDA7)

2011 ◽  
Vol 4 (21) ◽  
pp. 596-596
Blood ◽  
2017 ◽  
Vol 130 (6) ◽  
pp. 732-741 ◽  
Author(s):  
Michael D. Amatangelo ◽  
Lynn Quek ◽  
Alan Shih ◽  
Eytan M. Stein ◽  
Mikhail Roshal ◽  
...  

Key Points Enasidenib inhibits mIDH2, leading to leukemic cell differentiation with emergence of functional mIDH2 neutrophils in rrAML patients. RAS pathway mutations and increased mutational burden overall are associated with a decreased response rate to mIDH2 inhibition.


Sign in / Sign up

Export Citation Format

Share Document